Psychosocial factors associated with medication adherence in ethnically and socioeconomically diverse patients with epilepsy

Epilepsy and Behavior

Volumn 46, Issue , 2015, Pages 242-245

  Shallcross, Amanda J ^a   Becker, Danielle A ^a   Singh, Anuradha ^a   Friedman, Daniel ^a   Jurd, Rachel ^a   French, Jacqueline A ^a   Devinsky, Orrin ^a   Spruill, Tanya M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epilepsy; Medication adherence; Minority patients; Psychosocial factors; Race ethnicity; Social support

Indexed keywords

ANTICONVULSIVE AGENT;

8 ITEM MORISKY MEDICATION ADHERENCE SCALE; ADULT; ARTICLE; DEPRESSION; EPILEPSY; ETHNICITY; FEMALE; HEALTH BELIEF; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PATIENT COMPLIANCE; PREDICTION; QUESTIONNAIRE; RATING SCALE; SELF REPORT; SOCIAL BEHAVIOR; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SOCIOECONOMICS; STANDARDIZATION; ETHNIC GROUP; ETHNOLOGY; MEDICATION COMPLIANCE; MIDDLE AGED; NEW YORK; PSYCHOLOGY; SOCIAL CLASS;

ADULT; ANTICONVULSANTS; EPILEPSY; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEW YORK CITY; SOCIAL CLASS; SOCIAL SUPPORT;

EID: 84937968020     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.01.034     Document Type: Article

References (22)

1. Al-aqeel S., Al-sabhan J. Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy. Cochrane Database Syst Rev 2011, (1).
2. Hovinga C.A., Asato M.R., Manjunath R., Wheless JW, Phelps SJ, Sheth RD, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav 2008, 13(2):316-322.
3. Ettinger A.B., Good M.B., Manjunath R., Edward Faught R., Bancroft T. The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy. Epilepsy Behav 2014, 36:138-143.
4. de Souza E.A., Salgado P.C. A psychosocial view of anxiety and depression in epilepsy. Epilepsy Behav 2006, 8(1):232-238.
5. Carter J.A., Molyneux C.S., Mbuba C.K., Jenkins J., Newton C.R., Hartley S.D. The reasons for the epilepsy treatment gap in Kilifi, Kenya: using formative research to identify interventions to improve adherence to antiepileptic drugs. Epilepsy Behav 2012, 25(4):614-621.
6. Nakhutina L., Gonzalez J.S., Margolis S.A., Spada A., Grant A. Adherence to antiepileptic drugs and beliefs about medication among predominantly ethnic minority patients with epilepsy. Epilepsy Behav 2011, 22(3):584-586.
7. Jones R.M., Butler J.A., Thomas V.A., Peveler R.C., Prevett M. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure 2006, 15(7):504-508.
8. Khanna R., Pace P.F., Mahabaleshwarkar R., Basak R.S., Datar M., Banahan B.F. Medication adherence among recipients with chronic diseases enrolled in a state Medicaid program. Popul Health Manag 2012, 15(5):253-260.
9. Kroner B.L., Fahimi M., Kenyon A., Thurman D.J., Gaillard W.D. Racial and socioeconomic disparities in epilepsy in the District of Columbia. Epilepsy Res 2013, 103(2-3):279-287.
10. Morisky D.E., Ang A., Krousel-Wood M., Ward H.J. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008, 10(5):348-354.
11. Eze-Nliam C.M., Thombs B.D., Lima B.B., Smith C.G., Ziegelstein R.C. The association of depression with adherence to antihypertensive medications: a systematic review. J Hypertens 2010, 28:1785-1795.
12. Horne R., Weinman J., Hankins M. The Beliefs About Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999, 14(1):1-24.
13. Gilliam F.G., Barry J.J., Hermann B.P., Meador K.J., Vahle V., Kanner A.M. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 2006, 5(5):399-405.
14. Broadbent E., Petrie K.J., Main J., Weinman J. The Brief Illness Perception Questionnaire. J Psychosom Res 2006, 60(6):631-637.
15. Cohen S., Mermelstein R., Kamarck T., Hoberman H. Social support: theory, research, and applications. Measuring the functional components of social support 1985, Martinus Nijhoff, The Hague, pp. 73-94. I.G. Sarason, B.R. Sarason (Eds.).
16. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983, 24(4):385-396.
17. Gellad W.F., Grenard J.L., Marcum Z.A. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011, 9(1):11-23.
18. Kemp S., Feely M., Hay A., Wild H., Cooper C. Psychological factors and use of antiepileptic drugs: pilot work using an objective measure of adherence. Psychol Health Med 2007, 12(1):107-113.
19. DiMatteo M.R. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 2004, 23(2):207-218.
20. Lu B., Elliott J.O. Beyond seizures and medications: normal activity limitations, social support, and mental health in epilepsy. Epilepsia 2012, 53(2):e25-e28.
21. Landale N.S., Oropesa R.S., Bradatan C. Hispanic families in the United States: family structure and process in an era of family change. Vol Hispanics and the Future of America 2006, Washington DC, National Academies Press, pp. 138-178. M. Tienda, F. Mitchell (Eds.).
22. Merz E.L., Roesch S.C., Malcarne V.L., Penedo FJ, Llabre MM, Birnbaum-Weistzman OB, et al. Validation of Interpersonal Support Evaluation List-12 (ISEL-12) scores among English- and Spanish-speaking Hispanics/Latinos from the HCHS/SOL Sociocultural Ancillary Study. Psychol Assess 2013, 26:384-394.